CIV is a venture capital firm that backs and builds transformative technology companies reshaping critical industries, including energy transition, advanced manufacturing, industrial automation, and digital infrastructure. Founded by Patrick Maloney, Jeff Rosenthal, and Abhijoy Mitra, CIV operates from Venice Beach, California and closed its inaugural fund (CIV Fund One) at over $210 million.
Founded —
Type Venture capital 1 CIV Fund One 2025-04-29 2025-04-29 — OVERUSD210mclosedcapitalcommitments, notexactUSD210m. PriorCleanIndustryVenturesI2024-07-01FormDUSD200mofferingUSD54.338msold supersededforfinalclose, notAUM.
SHOW MORE
$3M $600K – $6M Cambridge, United Kingdom $3M $600K – $6M Cambridge, United Kingdom $3M $600K – $6M Cambridge, United Kingdom $3M $600K – $6M Cambridge, United Kingdom $3M $600K – $6M Cambridge, United Kingdom $3M $600K – $6M Cambridge, United Kingdom $3M $600K – $6M London $3M $600K – $6M Paris, France $1M $100K – $5M London $25K $5K – $50K Cambridge, United Kingdom — — – — — — – — — — – — — — – — — — – — — — – — — — – — — — – — — — – —
SHOW MORE
$65M 2026-07-15 Senra Systems Sequoia , 8VC , Alumni Ventures , CIV , Interlagos , Andreessen Horowitz $65M 2026-07-15 Senra Systems General Catalyst , 8VC , Alumni Ventures , CIV , Interlagos , Andreessen Horowitz $65M 2026-07-15 Senra Founders Fund , 8VC , Alumni Ventures , CIV , Interlagos , Andreessen Horowitz , General Catalyst , Sequoia $65M 2026-07-15 Senra Systems Founders Fund , 8VC , Alumni Ventures , CIV , Interlagos , Andreessen Horowitz $65M 2026-07-15 Senra Systems Founders Fund , 8VC , Alumni Ventures , Andreessen Horowitz , CIV , Interlagos $65M 2026-07-15 Senra Systems Founders Fund , 8VC , Alumni Ventures , Andreessen Horowitz , CIV , Interlagos , Paul Kwan $42M 2026-03-25 Sift CIV $50M 2026-03-09 Isembard CIV , IQ Capital , Notion Capital $— 2026 Calibre CIV $— 2025-12-03 Unlimited Industries CIV $— 2025-08-26 Aigent Energy CIV $51M 2025-05-16 The Nuclear Company Eclipse , CIV $9M 2025-04-24 Isembard Notion Capital , CIV , Jos White $30M 2025 Tahoe Therapeutics Amplify Partners , CIV , General Catalyst , Wing Venture Capital , Civilization Ventures , Conviction Partners , Databricks Ventures $— 2024-05-22 Verse CIV $2M 2023-02-09 Wyndly Y Combinator , Goodwater Capital , Civilization Ventures , Sweater Ventures , CIV $6M 2021-07-26 Glyphic Biotechnologies Cantos , CIV , Osage University Partners , Wing Venture Capital $2M 2021-04-19 Adyn Y Combinator , Lux Capital , Civilization Ventures , M13 , CIV $27M 2020-12-16 Curai Health General Catalyst , Khosla Ventures , Civilization Ventures , Morningside Ventures , CIV $— Unknown date Evonetix CIV $5M Unknown date Hypercubic Y Combinator , CIV , Pioneer Fund , Afore Capital $22M Unknown date Shinkei Founders Fund , CIV , Interlagos , Yamato Holdings , Shrug Capital $25M Unknown date Senra Systems Founders Fund , 8VC , CIV , General Catalyst , Sequoia Capital , Sequoia $6M 2025-08-26 AiGent CIV $— 2019-09-23 Kheiron Atomico , CIV $— Unknown date Range Biotechnologies CIV
SHOW MORE
team@apexlogos.ai · 16 hours ago
Investment-fund research reviewed 2026-10-06. Publicly identified funds, dates, amounts and fundraising status are below. Undisclosed commitments remain unknown; this is not a complete register of private SPVs or parallel entities.
Fund size and status
| Fund/evidence | Amount and meaning | Date and confidence |
|---|---|---|
| CIV Fund One | **More than US$210m in capital commitments**, oversubscribed inaugural fund, **closed** | Company-issued announcement 2025-04-29; high confidence as issuer-reported close. [Issuer release, syndicated from Business Wire](https://markets.financialcontent.com/stocks/article/bizwire-2025-4-29-civ-launches-with-210m-fund-to-back-and-build-companies-reshaping-critical-industries ). Original https://www.businesswire.com/news/home/20250429109039/en/ failed direct fetch. |
| Earlier regulatory offering | US$200m offering amount; US$54.338m sold at that filing, 71 investors | [SEC Form D/A signed 2024-07-01](https://www.sec.gov/Archives/edgar/data/1993392/000199339224000003/xslFormDX01/primary_doc.xml ). Issuer previously named Clean Industry Ventures I, L.P.; organized 2023. This is an earlier fundraising snapshot, superseded for final-close purposes by the 2025 announcement. |
Searches for CIV Fund Two/Fund II and newer CIV closes found no verified newer flagship close. **Latest-known** here means the newest close established by these checked sources, not proof that no later private raise exists. Special-purpose vehicles and regulatory gross asset values should not be equated with flagship fund commitments or added into total AUM. Verified firmwide AUM, investment budget, check sizes, reserve ratio and ownership targets were not found. An April 2025 Axios summary used US$200m for the debut fund; the later issuer close of more than US$210m is more precise and the discrepancy may reflect timing or rounding. [Axios, 2025-04-24](https://www.axios.com/newsletters/axios-pro-rata-b9de2644-9d2d-4b35-a804-aef1054bea7e ).
Funds recorded in Adex after this review:
| Fund | Disclosed amount | Announcement / filing date |
| --- | --- | --- |
| CIV Fund One | Undisclosed / unverified | 2025-04-29 | SHOW MORE
team@apexlogos.ai · 17 hours ago
Match research 2026-10-06 / CIV / sha256:f975d94dca06b33c3680a8c605a97949854343f0cf57e0baf521e57ebeeecbbb / part 2 of 2
Imported completed research. Baseline Adex/Signal statements describe prior state, not independent verification. Retain cited attribution, date, currency and classification caveats.
| **AiGent** | AI-based orchestration, controls and market integration for distributed generation assets. Power systems technology; primarily infrastructure software, not verified novel generation hardware. | **US$6m Seed, 2025-08-26**, led by Zero Infinity Partners and CIV. Release quotes CIV founder Patrick Maloney and links civ.co, strongly disambiguating the firm. | [AiGent company-issued release, 2025-08-26](https://www.prnewswire.com/news-releases/aigent-raises-6m-in-funding-to-couple-ai-with-distributed-generation-to-deliver-grid-reliability-at-scale-302538264.html ). |
| **Sift** | High-frequency sensor telemetry and observability for spacecraft, defense and autonomous hardware. Deep-tech enabling data infrastructure, not a hardware producer or evidence that all its AI is novel science. | CIV named participant in **US$42m Series B, announced 2026-03-25**, led by StepStone. Release says the round closed “last year,” so announcement date should not be treated as cash-closing date. | [Corrected Sift company-issued release, 2026-03-25](https://www.prnewswire.com/news-releases/sift-raises-42m-series-b-to-build-ai-infrastructure-for-mission-critical-machines-302724877.html ); [CIV portfolio](https://www.civ.co/portfolio ). |
The official portfolio additionally names Base, Giga Energy, Turgon AI, Crux, 1001, Verse, Unlimited Industries, General Biological, 1AP, Starpilot, Calibre, APD, Mundane, Hypercubic and ArgusEye. [CIV portfolio, undated, accessed 2026-10-06](https://www.civ.co/portfolio ). These are useful leads; individual rounds and deep-tech eligibility were not exhaustively verified. Ordinary finance/software exposure is not automatically deep tech.
## Previous neurotech investments
**No verified neurotech investment found in the sources checked.** Checked evidence comprises the exact Adex snapshot, Signal access/search attempts, CIV's official portfolio and build/team pages, and searches combining CIV with neurotech, neural and brain investments.
The snapshot's **Tacit Therapeutics** lead is a concrete attribution error for this firm's identity: Tacit's own [announcement dated 2026-03-09](https://tacittx.com/news/tacit-launches-with-19m-to-advance-rna-repair-platform-for-neurological-diseases/ ) names **Civilization Ventures**, with KdT Ventures leading and Michigan Capital Network participating. Direct fetch failed with 404, but the official page's search index supplied these facts. [Tacit's official About page](https://tacittx.com/about/ ) also displays Civilization Ventures support, and [Civilization Ventures' official portfolio](https://www.civilizationventures.com/portfolio ) lists Tacit. This is RNA repair/gene therapy initially addressing inherited neurological diseases: neuroscience therapeutics adjacency, not a verified neural sensing, stimulation or brain-interface device. Its US$19m is **total capital raised**, not necessarily the Series A round size, and is not a CIV fund amount.
Shinkei's fish neural-destruction harvesting technique and Senra's figurative description of wire harnesses as a “nervous system” do not constitute human neurotechnology exposure. Partner angel investments or advisory relationships, including Rosenthal's earlier SpaceX investment and Calm advisory reference in the launch release, must not be attributed to CIV; Calm is also mental wellness rather than verified direct neurotechnology.
## Conflicts, missing information and later Adex review notes
1. **Resolve the three-firm conflation before any update:** industrial CIV/civ.co; Cambridge Innovation Capital/cic.vc; Civilization Ventures/civilizationventures.com. The latter's official portfolio matches many health/biology entries in this snapshot, including Foresight Diagnostics, BillionToOne, Omada Health, Evonetix, Glyphic Bio, IanTrek, Infinimmune, Kernal Bio, Kheiron, OverT, OXCan and Tacit. Do not automatically move rows without checking the original investor named in each announcement. [Civilization Ventures official portfolio, undated](https://www.civilizationventures.com/portfolio ).
2. Review snapshot team roles 8465–8474 against CIC's official team; historical roles and misspellings (for example Edward Inns versus snapshot EdwardInns) need separate identity checks. Retain confirmed industrial CIV founder/team identities from civ.co.
3. Deduplicate Senra/Senra Systems rows only after reviewing company IDs and source provenance. The official US$65m release dates the event **2026-07-15**; a CB Insights search result gave 2026-04-15, which conflicts and should not override the company announcement.
4. The snapshot's Isembard seed attribution remains unverified: its linked [2025-04-24 article](https://techcrunch.com/2025/04/24/british-startup-isembard-lands-9m-to-reshore-manufacturing-for-critical-industries/ ) does not name CIV. Later portfolio attribution cannot establish participation in that round.
5. Snapshot Calibre points to a healthtech story, while CIV's portfolio may concern an auditing/infrastructure company with the same name. Identity and URL should be reconciled before accepting that row. Do not infer healthtech exposure from a shared name.
6. Record CIV Fund One as **>US$210m closed commitments, announced 2025-04-29**. Keep SEC offering amount, gross assets, total AUM and company financing sizes separate. No verified newer flagship fund, current check range, exact comprehensive stage mandate or exhaustive neurotech coverage was established.
7. Primary issuer announcements are attribution evidence but self-reported business/technology claims. Official portfolios establish company-level exposure, not necessarily a particular fund, round, check size or lead role. The Signal access failures and search-index-only Tacit evidence limit confidence in those specific starting sources.
This file is research for later Adex review only. No Adex/database changes, MCP Patch, commits or manifest edits were performed by this researcher. SHOW MORE
team@apexlogos.ai · 17 hours ago
Match research 2026-10-06 / CIV / sha256:f975d94dca06b33c3680a8c605a97949854343f0cf57e0baf521e57ebeeecbbb / part 1 of 2
Imported completed research. Baseline Adex/Signal statements describe prior state, not independent verification. Retain cited attribution, date, currency and classification caveats.
# CIV
- Exact Adex ID: `CIV`
- Canonical Adex record: https://adex.page/firms/CIV
- Official website: https://www.civ.co/
- Research date and all source access dates: **2026-10-06**
- Status: **Complete for the requested research fields; material identity and source limitations recorded below.**
CIV is the Venice Beach industrial technology investment firm and company builder founded by Patrick Maloney, Jeff Rosenthal and Abhijoy Mitra. Its latest-known verified flagship close is CIV Fund One, with more than US$210 million of commitments announced in April 2025. It has verified industrial technology investments, but no verified direct neurotechnology investment in the sources checked. The saved Adex record materially conflates this firm with Cambridge Innovation Capital and Civilization Ventures; resolving attribution is a priority for later review.
## Adex and NFX Signal starting evidence
The exact-ID saved MCP snapshot, `data/research/_sources/CIV.adex.json`, was retrieved 2026-10-06 at 19:29:08 UTC. It describes industrial CIV and links civ.co, https://signal.nfx.com/firms/civ and Goldi.ai. Its investor profile has no check minimum, maximum or sweet spot. Investments include Senra Systems, Shinkei, Sift, Isembard, AiGent, The Nuclear Company and Verse, alongside numerous biotech and health investments. Six Senra/Senra Systems rows appear to represent the same US$65m event on 2026-07-15. These records are starting claims, not independent verification.
The snapshot lists the actual industrial CIV founders and team, but also Andrew Williamson, Michael Anstey, Anne Horgan, Ian Lane, Rob Sprawson, Robert Tansley and other Cambridge-related personnel. [Cambridge Innovation Capital's official team](https://www.cic.vc/team/ ) directly identifies those people with **CIC**, while [CIV's official team](https://www.civ.co/about ) identifies Maloney, Rosenthal and Mitra and the industrial CIV team. Both pages are undated, accessed 2026-10-06. This establishes an entity conflation, not an alternative CIV spelling.
**Signal access:** The supplied https://signal.nfx.com/firms/civ returned an internal fetch error on direct opening. Searches for that exact URL and CIV founders did not yield a reliable readable firm profile. A guessed https://signal.nfx.com/investors/jeff-rosenthal also failed. Consequently no fund size, check range, current-stage mandate or investment list is accepted from Signal for industrial CIV. A search-index-accessible [Andrew Williamson Signal profile](https://signal.nfx.com/investors/andrew-williamson ) instead identifies **Cambridge Innovation Capital**, showing £225m fund size and Seed/Series A rankings; these claims belong to another firm and must not be imported into CIV. That Signal page was search-index accessible, not independently verified as a current mandate.
## Fund size and status
| Fund/evidence | Amount and meaning | Date and confidence |
|---|---|---|
| CIV Fund One | **More than US$210m in capital commitments**, oversubscribed inaugural fund, **closed** | Company-issued announcement 2025-04-29; high confidence as issuer-reported close. [Issuer release, syndicated from Business Wire](https://markets.financialcontent.com/stocks/article/bizwire-2025-4-29-civ-launches-with-210m-fund-to-back-and-build-companies-reshaping-critical-industries ). Original https://www.businesswire.com/news/home/20250429109039/en/ failed direct fetch. |
| Earlier regulatory offering | US$200m offering amount; US$54.338m sold at that filing, 71 investors | [SEC Form D/A signed 2024-07-01](https://www.sec.gov/Archives/edgar/data/1993392/000199339224000003/xslFormDX01/primary_doc.xml ). Issuer previously named Clean Industry Ventures I, L.P.; organized 2023. This is an earlier fundraising snapshot, superseded for final-close purposes by the 2025 announcement. |
Searches for CIV Fund Two/Fund II and newer CIV closes found no verified newer flagship close. **Latest-known** here means the newest close established by these checked sources, not proof that no later private raise exists. Special-purpose vehicles and regulatory gross asset values should not be equated with flagship fund commitments or added into total AUM. Verified firmwide AUM, investment budget, check sizes, reserve ratio and ownership targets were not found. An April 2025 Axios summary used US$200m for the debut fund; the later issuer close of more than US$210m is more precise and the discrepancy may reflect timing or rounding. [Axios, 2025-04-24](https://www.axios.com/newsletters/axios-pro-rata-b9de2644-9d2d-4b35-a804-aef1054bea7e ).
## Investment stages and current strategy
CIV's official [Build Program](https://www.civ.co/build-with-us ) explicitly supports incubation, company formation and seed investment, including co-founding and seeding The Nuclear Company. Its [About page](https://www.civ.co/about ) lists energy/resources, digital/data infrastructure, mobility/transportation, advanced manufacturing/industrial automation, and built environment/infrastructure. These are undated current website statements accessed 2026-10-06.
Verified transaction history includes **Seed** (AiGent), **Series A** (Isembard, Shinkei) and **Series B** (Senra, Sift), as documented below. Thus formation and early-stage investing are clearly supported, with later follow-on participation. No official exhaustive stage range or exclusion policy was found. Do not convert partners' earlier growth-stage investing at Coatue or Valor into CIV's mandate. A third-party database's “Pre-Seed–Series A” label is too narrow to describe the observed Series B participations and is not used as official strategy.
## Named previous deep-tech and industrial technology investments
Amounts below are **company round sizes**, not CIV's invested amounts, unless explicitly stated. CIV-specific check amounts were not disclosed. Classification reflects the technology described; infrastructure developers and specialist software are distinguished from novel hardware or scientific platforms.
| Company | Technology rationale and classification | Verified attribution, round and dates | Supporting sources |
|---|---|---|---|
| **Senra Systems** | Software-enabled wire harness manufacturing and automation for aerospace/defense; advanced manufacturing rather than generic SaaS. | CIV named participant in **US$65m Series B, 2026-07-15**, co-led by Lowercarbon Capital and Interlagos. Firm website also lists Senra. | [Senra official announcement, 2026-07-15](https://www.senrasystems.us/media/announcing-our-series-b ); [CIV portfolio, undated](https://www.civ.co/portfolio ). |
| **The Nuclear Company** | Fleet-scale nuclear deployment, advanced manufacturing and energy infrastructure. Nuclear technology exposure is verified; this is not evidence of a new reactor design or a novel reactor physics startup. | CIV **co-founded and seeded** the company, alongside Jonathan Webb and Kiran Bhatraju; Patrick Maloney is co-founder/chairman. Seed amount and initial date not disclosed on the checked official case study. | [CIV Build Program/case study, undated](https://www.civ.co/build-with-us ). |
| **Shinkei Systems** | Poseidon seafood harvesting robots integrating computer vision and physical automation; clear robotics exposure. | CIV official portfolio attribution; **US$22m Series A** participant reported in June 2025, with Founders Fund and Interlagos co-leading. Exact announcement day not settled by the sources used. | [CIV portfolio, undated](https://www.civ.co/portfolio ); [Shinkei official technology description, undated](https://shinkei.systems/ ); [Axios June 2025 reporting](https://www.axios.com/newsletters/axios-pro-rata-f0d529b2-68fd-4204-983c-c65a33cb5c46 ). |
| **Isembard** | Precision manufacturing factories powered by proprietary MasonOS; industrial automation and manufacturing infrastructure. Novelty/deep-tech depth should not be inferred solely from its AI label. | CIV listed on official firm portfolio; **US$50m Series A, 2026-03-09**, participation reported by Tech.eu. USV led. | [CIV portfolio, undated](https://www.civ.co/portfolio ); [Isembard official site, undated](https://isembard.com/uk/ ); [Tech.eu, 2026-03-09](https://tech.eu/2026/03/09/uk-manufacturing-startup-isembard-secures-50m/ ); [Notion investor announcement, 2026-03-09](https://www.notioncapital.com/resources/the-next-chapter-for-isembard ). | SHOW MORE
team@apexlogos.ai · 23 days ago
MATCH 
8VC
Senra Systems$65M · 2026-07-15
Senra$65M · 2026-07-15
Shinkei$22M · Unknown date
Alumni Ventures
Andreessen Horowitz
Founders Fund
General Catalyst
Tahoe Therapeutics$30M · 2025
Curai Health$27M · 2020-12-16
Wyndly$2M · 2023-02-09
Adyn$2M · 2021-04-19
Sequoia
Y Combinator
Hypercubic$5M · Unknown date
Wing Venture Capital
Glyphic Biotechnologies$6M · 2021-07-26
Afore Capital
Amplify Partners
Cantos
Eclipse
The Nuclear Company$51M · 2025-05-16
IQ Capital
Isembard$50M · 2026-03-09
Khosla Ventures
Lux Capital
Morningside Ventures
Osage University Partners
Paul Kwan
